Literature DB >> 19436788

First report of tirofiban-induced anemia (found in combination with severe thrombocytopenia).

Dimitris Sakellariou1, Socrates Pastromas, Spyridon Koulouris, Antonis S Manolis.   

Abstract

We describe the case of a 58-year-old man who developed acute severe anemia and thrombocytopenia after the administration of tirofiban following coronary artery angioplasty. The intravenous administration of IgG immunoglobulin completely resolved both the anemia and the thrombocytopenia. Although thrombocytopenia has been reported as a sequela to the use of tirofiban, there has been no prior report of a link between tirofiban use and anemia. Our successful resolution of both the anemia and the thrombocytopenia with immunoglobulin supports the theory that these severe sequelae of tirofiban are of autoimmune origin.

Entities:  

Keywords:  Anemia; platelet aggregation inhibitors; platelet glycoprotein GPIIb/IIIa complex/drug effects; thrombocytopenia; tirofiban

Mesh:

Substances:

Year:  2009        PMID: 19436788      PMCID: PMC2676520     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  10 in total

Review 1.  Understanding thrombocytopenia and antigenicity with glycoprotein IIb-IIIa inhibitors.

Authors:  M Madan; S D Berkowitz
Journal:  Am Heart J       Date:  1999-10       Impact factor: 4.749

Review 2.  Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.

Authors:  J E Tcheng
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

Review 3.  Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists.

Authors:  Lindsay M Huxtable; Mohammad J Tafreshi; Amol N S Rakkar
Journal:  Am J Cardiol       Date:  2005-12-01       Impact factor: 2.778

Review 4.  Drug-induced immune thrombocytopenia: an overview of pathogenesis.

Authors:  R H Aster
Journal:  Semin Hematol       Date:  1999-01       Impact factor: 3.851

5.  Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1998-05-21       Impact factor: 91.245

6.  Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis.

Authors:  H Dasgupta; J C Blankenship; G C Wood; C M Frey; S L Demko; F J Menapace
Journal:  Am Heart J       Date:  2000-08       Impact factor: 4.749

7.  Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions.

Authors:  Evangelia Karvouni; Demosthenes G Katritsis; John P A Ioannidis
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

8.  Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.

Authors:  Daniel W Bougie; Peter R Wilker; Elizabeth D Wuitschick; Brian R Curtis; Mohammad Malik; Stewart Levine; Richard N Lind; Jaime Pereira; Richard H Aster
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

9.  Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.

Authors:  Piera Angelica Merlini; Marco Rossi; Alberto Menozzi; Silvia Buratti; Danielle M Brennan; David J Moliterno; Eric J Topol; Diego Ardissino
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

Review 10.  Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.

Authors:  Charles S Abrams; Douglas B Cines
Journal:  Curr Hematol Rep       Date:  2004-03
  10 in total
  2 in total

Review 1.  Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review.

Authors:  Omer Celal Elcioglu; Abdullah Ozkok; Timur Selcuk Akpınar; Fatih Tufan; Murat Sezer; Sabahattin Umman; Sevgi Kalayoglu Besısık
Journal:  Int J Hematol       Date:  2012-07-06       Impact factor: 2.490

2.  An Unusual Case of Drug-Induced Thrombocytopenia.

Authors:  Shiyu Wang; Khalid Sawalha; Atif Khan
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.